- Home
- AMWD vs MDXG Comparison
AMWD vs MDXG Comparison
Compare AMWD & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- MDXG
- Stock Information
- Founded
- AMWD 1980
- MDXG 2006
- Country
- AMWD United States
- MDXG United States
- Employees
- AMWD N/A
- MDXG N/A
- Industry
- AMWD Forest Products
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- AMWD Basic Materials
- MDXG Health Care
- Exchange
- AMWD Nasdaq
- MDXG Nasdaq
- Market Cap
- AMWD 940.7M
- MDXG 1.1B
- IPO Year
- AMWD N/A
- MDXG N/A
- Fundamental
- Price
- AMWD $67.61
- MDXG $6.94
- Analyst Decision
- AMWD Buy
- MDXG Buy
- Analyst Count
- AMWD 3
- MDXG 1
- Target Price
- AMWD $70.00
- MDXG $12.00
- AVG Volume (30 Days)
- AMWD 189.7K
- MDXG 439.7K
- Earning Date
- AMWD 08-26-2025
- MDXG 10-29-2025
- Dividend Yield
- AMWD N/A
- MDXG N/A
- EPS Growth
- AMWD N/A
- MDXG N/A
- EPS
- AMWD 5.62
- MDXG 0.21
- Revenue
- AMWD $1,653,503,000.00
- MDXG $363,774,000.00
- Revenue This Year
- AMWD N/A
- MDXG $12.68
- Revenue Next Year
- AMWD $4.06
- MDXG $8.18
- P/E Ratio
- AMWD $12.03
- MDXG $32.78
- Revenue Growth
- AMWD N/A
- MDXG 6.85
- 52 Week Low
- AMWD $50.00
- MDXG $5.47
- 52 Week High
- AMWD $104.28
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- AMWD 56.89
- MDXG 46.17
- Support Level
- AMWD $64.25
- MDXG $6.89
- Resistance Level
- AMWD $70.07
- MDXG $7.14
- Average True Range (ATR)
- AMWD 2.38
- MDXG 0.18
- MACD
- AMWD -0.06
- MDXG -0.04
- Stochastic Oscillator
- AMWD 51.62
- MDXG 29.55
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.